Saturday 17 October 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
222.66
1.67
−0.74%
Follow STE
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
9 | 8 | 7 | 5 | 4 | 3 | 8 | 8 | 8 | 5 |
P/E ratio |
27.78 | 36.38 | 57.71 | 175.49 | 99.91 | 41.05 | 29.10 | 35.30 | 26.54 | 54.27 |
Altman Z-Score |
5.10 | 5.07 | 3.99 | 3.45 | 3.75 | 4.91 | 4.99 | 4.77 | 3.60 | 2.79 |
P/S ratio |
3.66 | 4.09 | 4.25 | 4.20 | 5.58 | 5.22 | 3.92 | 3.87 | 2.95 | 2.27 |
Altman Z″-Score (non-manufacturers) |
4.50 | 3.97 | 3.67 | 3.11 | 2.81 | 3.68 | 4.30 | 3.94 | 3.68 | 3.18 |
P/FCF ratio |
22.09 | 28.39 | 35.20 | 46.57 | 59.10 | 35.99 | 31.21 | 30.33 | 26.30 | 23.19 |
P/Operating CF |
64.74 | 85.69 | 85.69 | 88.38 | 137.31 | 86.39 | 59.56 | 60.24 | 59.64 | 44.08 |
Beneish M-Score |
(2.68) | (2.59) | (2.56) | (2.47) | (2.44) | (2.65) | (2.58) | (2.67) | (2.47) | (2.79) |
Dividend Safety Score |
86 | — | — | — | — | — | — | — | — | — |
P/B ratio |
3.02 | 3.38 | 3.46 | 3.13 | 3.60 | 4.17 | 3.47 | 3.38 | 2.41 | 2.11 |
Price to Tangible BV |
15.71 | 33.57 | 174.21 | 145.30 | 0.00 | 0.00 | 23.89 | 41.73 | 136.93 | 0.00 |
EV/Sales |
3.91 | 4.44 | 4.83 | 4.84 | 6.23 | 5.69 | 4.20 | 4.22 | 3.38 | 2.73 |
EV/EBITDA |
14.61 | 18.04 | 17.66 | 16.24 | 23.98 | 23.04 | 17.32 | 18.43 | 15.31 | 15.09 |
EV/Operating CF |
17.30 | 21.10 | 25.52 | 28.99 | 38.44 | 25.64 | 21.53 | 21.76 | 19.35 | 16.82 |
EV/FCF |
23.61 | 30.77 | 40.03 | 53.57 | 65.97 | 39.21 | 33.45 | 33.04 | 30.09 | 27.86 |
Quick Ratio |
1.34 | 1.19 | 1.31 | 1.25 | 1.24 | 1.44 | 1.80 | 1.69 | 1.83 | 2.01 |
Current Ratio |
2.09 | 1.96 | 3.08 | 2.33 | 2.04 | 2.10 | 2.43 | 2.27 | 2.48 | 2.67 |
Net Debt/EBITDA |
0.94 | 1.39 | 2.13 | 2.12 | 2.50 | 1.89 | 1.16 | 1.51 | 1.93 | 2.53 |
Debt/Assets |
17.99% | 20.14% | 28.98% | 28.45% | 27.03% | 25.46% | 21.51% | 23.32% | 25.31% | 30.02% |
Debt/Equity |
0.27 | 0.31 | 0.51 | 0.51 | 0.47 | 0.43 | 0.34 | 0.37 | 0.41 | 0.53 |
Asset Turnover |
0.57 | 0.51 | 0.47 | 0.41 | 0.47 | 0.52 | 0.58 | 0.54 | 0.52 | 0.51 |
Operating CF/Net income |
1.71 | 1.87 | 2.57 | 7.07 | 2.81 | 1.74 | 1.45 | 1.78 | 1.57 | 3.86 |
Capex/Depreciation |
(0.74) | (0.76) | (0.62) | (0.62) | (0.46) | (1.09) | (1.07) | (0.82) | (0.92) | (0.68) |
Interest Coverage |
18.15 | 10.04 | 5.79 | 7.33 | 5.34 | 14.75 | 13.33 | 9.13 | 7.90 | 5.08 |
| 11.33% | 9.51% | 6.10% | 1.69% | 4.67% | 10.87% | 12.35% | 9.49% | 9.65% | 3.76% | |
| 7.49% | 5.80% | 3.46% | 0.96% | 2.71% | 6.61% | 7.75% | 5.91% | 5.75% | 2.14% | |
ROIC |
7.92% | 6.38% | 5.61% | 5.52% | 3.22% | 6.41% | 7.86% | 6.19% | 5.77% | 3.53% |
Return on Tangible Assets |
22.94% | 20.94% | 10.21% | 3.85% | 9.72% | 21.26% | 22.25% | 18.75% | 18.16% | 7.08% |
Average Days of Receivables |
67.20 | 69.80 | 71.62 | 69.60 | 69.06 | 71.58 | 70.63 | 74.10 | 73.57 | 67.54 |
Research and Development Expense of Revenue |
1.90% | 1.97% | 2.02% | 2.17% | 2.05% | 2.13% | 2.16% | 2.27% | 2.32% | 2.27% |
Selling, General and Administrative Expense of Revenue |
23.72% | 24.44% | 24.37% | 24.04% | 31.22% | 23.53% | 23.65% | 24.08% | 24.12% | 26.10% |
Intangible Assets out of Total Assets |
0.54 | 0.59 | 0.56 | 0.55 | 0.68 | 0.60 | 0.54 | 0.58 | 0.61 | 0.60 |
Share Based Compensation of Revenue |
1.04% | 1.05% | 1.10% | 0.86% | 1.37% | 0.84% | 0.79% | 0.86% | 0.85% | 0.72% |
Graham Net Nets |
(0.05) | (0.07) | (0.09) | (0.14) | (0.13) | (0.09) | (0.07) | (0.08) | (0.13) | (0.18) |
Graham Number |
114.57 | 96.98 | 74.22 | 38.69 | 60.45 | 69.05 | 66.06 | 55.31 | 54.04 | 30.77 |
Earnings Yield |
3.60% | 2.75% | 1.73% | 0.57% | 1.00% | 2.44% | 3.44% | 2.83% | 3.77% | 1.84% |
Free Cash Flow Yield |
4.53% | 3.52% | 2.84% | 2.15% | 1.69% | 2.78% | 3.20% | 3.30% | 3.80% | 4.31% |
Revenue per Share |
60.45 | 55.37 | 52.01 | 45.50 | 43.30 | 36.47 | 35.75 | 32.90 | 30.81 | 30.57 |
Operating CF per Share |
13.66 | 11.64 | 9.85 | 7.59 | 7.02 | 8.09 | 6.97 | 6.38 | 5.38 | 4.96 |
Capex per Share |
(3.65) | (3.66) | (3.57) | (3.48) | (2.93) | (2.80) | (2.48) | (2.18) | (1.92) | (1.97) |
Free Cash Flow per Share |
10.01 | 7.98 | 6.28 | 4.11 | 4.09 | 5.29 | 4.48 | 4.20 | 3.46 | 3.00 |
Cash per Share |
4.48 | 1.74 | 2.10 | 2.09 | 3.57 | 2.59 | 3.77 | 2.61 | 2.37 | 3.31 |
Shareholders Equity per Share |
73.29 | 67.10 | 63.92 | 61.05 | 67.10 | 45.67 | 40.32 | 37.67 | 37.84 | 32.88 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
73.29 | 67.10 | 63.92 | 61.05 | 67.10 | 45.67 | 40.32 | 37.67 | 37.84 | 32.88 |
Free Cash Flow |
982.90 | 787.20 | 620.40 | 409.57 | 398.99 | 450.95 | 380.20 | 355.36 | 294.27 | 256.03 |
Working Capital |
1,249.60 | 978.60 | 1,938.00 | 1,149.60 | 956.78 | 633.83 | 720.43 | 588.54 | 591.20 | 636.22 |
Capital Expenditures |
(358.50) | (360.90) | (352.90) | (347.38) | (285.82) | (238.69) | (210.36) | (184.15) | (163.36) | (168.05) |
Net Current Asset Value |
(1,145.40) | (1,530.30) | (1,879.23) | (2,723.22) | (2,999.96) | (1,471.25) | (798.62) | (833.54) | (993.38) | (1,096.62) |
EV/EBIT |
21.06 | 27.95 | 29.71 | 27.74 | 55.09 | 32.25 | 23.68 | 28.56 | 22.14 | 31.53 |
Capex to Sales |
0.06 | 0.07 | 0.07 | 0.08 | 0.07 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 |
Price to Operating Income |
19.71 | 25.79 | 26.12 | 24.11 | 49.35 | 29.60 | 22.10 | 26.22 | 19.35 | 26.25 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.23 | 0.24 | 0.32 | 0.34 | 0.40 | 0.18 | 0.18 | 0.22 | 0.18 | 0.27 |
Cash ROIC |
10.27% | 8.91% | 6.38% | 4.37% | 4.00% | 7.79% | 7.75% | 7.74% | 6.21% | 5.60% |
Accounts Receivable Turnover |
5.56 | 5.32 | 5.49 | 5.45 | 6.00 | 5.20 | 5.27 | 5.09 | 5.18 | 5.47 |
Accounts Payable Turnover |
10.68 | 11.48 | 11.32 | 10.43 | 12.23 | 11.52 | 11.32 | 11.13 | 11.34 | 11.62 |
Inventory Turnover |
5.46 | 4.87 | 4.57 | 4.33 | 5.26 | 6.10 | 7.25 | 7.76 | 7.57 | 8.12 |
Average Days of Payables |
37.37 | 33.53 | 31.46 | 37.73 | 35.21 | 32.47 | 31.86 | 34.73 | 32.47 | 30.71 |
Days of Inventory on Hand |
69.68 | 69.41 | 84.30 | 86.33 | 89.67 | 65.18 | 56.22 | 47.29 | 49.17 | 45.51 |
Average Receivables |
1,068.40 | 1,026.16 | 936.65 | 832.01 | 704.22 | 597.94 | 575.66 | 546.45 | 505.76 | 477.49 |
Average Payables |
309.80 | 266.26 | 257.94 | 244.95 | 191.34 | 153.15 | 151.13 | 144.39 | 134.67 | 136.53 |
Average Inventory |
606.55 | 627.92 | 639.47 | 589.70 | 445.03 | 289.31 | 235.89 | 206.99 | 201.78 | 195.31 |
Average Assets |
10,442.00 | 10,605.25 | 10,942.77 | 11,122.72 | 8,999.03 | 6,007.67 | 5,256.97 | 5,136.70 | 5,062.39 | 5,135.44 |
Average Common Equity |
6,906.55 | 6,465.57 | 6,201.26 | 6,315.90 | 5,218.05 | 3,654.84 | 3,302.00 | 3,201.54 | 3,013.65 | 2,924.45 |
Columns are period end dates